Newsroom

News

On Wednesday, April 22, 2026, State Secretary of the Federal Ministry of Research, Technology, and Space (BMFTR), Dr. Rolf-Dieter Jungk, visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig. Led by HZI Directors Prof. Josef Penninger and Christian Scherf, as well as Prof. Theresia Stradal, spokesperson for the HZI campus in Braunschweig, he gained a comprehensive insight into the center’s cutting-edge research. The visit focused on the junior research research groups of the BMFTR-funded MICROSTAR program as well as the HZI’s organoid platform.

23.04.2026

HZI Campus

A man and a woman are both wearing lab coats. They are seen in a laboratory, looking at a screen

News

Joint pain, skin changes, extreme fatigue – and often no clear diagnosis for years: collagen diseases can present in a wide variety of ways and place a significant burden on those affected. In these rare inflammatory rheumatic conditions, the immune system attacks the body’s own tissues, particularly the connective tissue. As virtually any organ can be affected, collagen diseases can, in the worst-case scenario, become life-threatening. A project by Hannover Medical School (MHH), TWINCORE – Centre for Experimental and Clinical Infection Research, and the Helmholtz Centre for Infection Research (HZI) is now developing more accurate diagnoses for better treatments of collagen diseases.

21.04.2026

TWINCORE

Group photo with three people standing side by side and a building in the background

News

A recent study from Hannover provides important insights into the understanding and future treatment of chronic hepatitis B. Researchers from the Hannover Medical School (MHH), the Helmholtz Centre for Infection Research (HZI), TWINCORE and the Centre for Individualised Infection Medicine (CiiM) have demonstrated that a previously little-noticed group of immune cells – so-called γδ T cells – plays a central role in controlling the viral infection. The study was published in the journal Gut. TWINCORE and CiiM are joint institutions of the HZI and the MHH.

20.04.2026

TWINCORE

CiiM

News

In March 2026, the Europe-wide doctoral program “UNLIMITED – Understanding Lipid Immunometabolism to Treat Disease” was launched under the leadership of the University Medical Center Mainz. In cooperation with the Technische Universität Braunschweig, a doctoral position will also be established in a research group at the Helmholtz Centre for Infection Research (HZI). The project is funded by the European Commission under the prestigious Marie Skłodowska-Curie Actions (MSCA) with a total of 4.5 million euros and is one of 149 doctoral networks currently funded across the EU.

16.04.2026

BRICS

News

The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the emphasis has been on its underlying mechanisms and nucleases. In contrast, little research has examined how CRISPR-Cas systems have evolved and been optimized. In collaboration with the universities of Leipzig, Freiburg, and Michigan (USA), a research team at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg found an optimization mechanism in CRISPR-Cas13, providing insights into the evolution of these systems. The results were recently published in EMBO Journal.

14.04.2026

HIRI

Section of a mouse dorsal root ganglion with two subtypes of pain receptors marked in cyan and magenta.

News

Helmholtz researchers have created the first detailed protein map of specific sensory neurons that trigger pain. The team from the Max Delbrück Center and the Helmholtz Centre for Infection Research (HZI) determined the complete set of proteins in nerve cells and generated a high-resolution map of the cells. Their study, published in “Nature Communications,” will help researchers better understand the molecular mechanisms of chronic inflammatory pain and identify new drug targets.

14.04.2026

HZI Campus

Back to the first page
...
9
10
11
12
...
164

HZI in the media

... ist Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung (HZI) und Mitglied der Ständigen Impfkommission ...

30.10.2026

Focus Online

von Mikroorganismen und Zellkulturen und des Helmholtz-Zentrums für Infektionsforschung zwei bislang unbekannte Naturstoffe entdeckt. Die

30.10.2026

Bionity.COM

Researchers at the Helmholtz Centre for Infection Research (HZI) and its Saarland University partner site, the Helmholtz Institute for

27.10.2026

Scienmag Science Magazine

experimental and modeling study led by scientists at the Helmholtz Centre for Infection Research in Braunschweig. The researchers found that

26.10.2026

Bioengineer.org

... am Helmholtz Zentrum für Infektionsforschung (HZI) und dessen Saarbrücker Standort, dem Helmholtz-Institut für Pharmazeutische ...

26.10.2026

Verband Deutscher Biologen e.V.

Dr. Milan Gerovac, Nachwuchsgruppenleiter am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig, erhält den begehrten ...

24.10.2026

Homburg

heads the Research Group “Molecular Cell Biology” at the Helmholtz Center for Infection Research (HZI), has shed new light on the central

23.10.2026

Health Medicine Network

... “

Das Helmholtz-Zentrum für Infektionsforschung: Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung (HZI) untersuchen ...

22.10.2026

DeutschesGesundheitsPortal

... Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

22.10.2026

DIE WELT

... befallen. Am HZI in Braunschweig wird daran geforscht.

Am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig ...

22.10.2026

NDR Norddeutscher Rundfunk

are extremely complex.

Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have now shown that artificial

21.10.2026

Phys.org

Würzburg (JMU) und dem Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des HZI in ...

20.10.2026

Regional Heute

Register now for the HZI newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.